show episodes
 
Artwork

1
CCO Oncology Podcast

Clinical Care Options

Unsubscribe
Unsubscribe
Μηνιαία+
 
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
  continue reading
 
Artwork

1
Oncology Congress

Oncology Congress

Unsubscribe
Unsubscribe
Μηνιαία
 
Oncology Congress provides US-based, practicing oncologists, nurses and pharmacists with the latest clinical data, best practices, and technology-driven innovations that directly enhance clinical practice and patient care.
  continue reading
 
The EMJ Podcast is an educational podcast for healthcare professionals that covers the forefront of clinical practice, offering insights into the cutting edge of medicine. Through conversations with key opinion leaders, our host, physician and entrepreneur Jonathan Sackier, explores the latest trends and innovations, covering a number of clinical specialties, including oncology, dermatology, urology, cardiology, and many more.
  continue reading
 
Artwork

1
OT Broadcast News

Oncology Times

Unsubscribe
Unsubscribe
Μηνιαία
 
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
  continue reading
 
Loading …
show series
 
This week Jonathan is joined by Isabelle Amigues, CEO and Founder of UnabridgedMD, Denver, Colorado, USA. Together, they discuss the first part of her career as an academic clinician followed by how her diagnosis of Stage IV breast cancer shaped her approach to use the best in data-driven Western medicine combined with traditional Eastern healing. …
  continue reading
 
In this episode of Hema Now, Dr. Jonathan Sackier welcomes Professor Antonio Almeida, a leader in hematology and the 2024 President of the EHA. They delve into the highlights from this year’s EHA Congress, discuss the founding of the Católica Medical School, and explore the transformative role of AI in healthcare. Timestamps: (00:00) -Introduction …
  continue reading
 
This week, Jonathan Sackier is joined by Prof. Carlos Caldas, a world-leading expert in breast cancer research and clinician scientist at the University of Cambridge. Together, they explore how genomic-based classifications of breast cancer are transforming treatment strategies and improving patient outcomes. Timestamps: (00:00) – Introduction (02:…
  continue reading
 
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D The role of bispecific antibodies in R/R MM Safety considerations for patients while receiving a bispecific antibody Emerging…
  continue reading
 
In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital. Stone discusses his groundbreaking work in systemic vasculitis, including granulomatosis with polyangiitis and ANCA-associated vasculitis. He also shares insights into the e…
  continue reading
 
In this exclusive podcast, experts in the field, Andrew Foy, Penn State Health Milton S. Hershey Medical Center, and Ed Filippone, Sidney Kimmel Medical College of Thomas Jefferson University, both in Pennsylvania, USA, explore the burden of hypertension on patients and give insights into how to best care for these patients. Topics covered include:…
  continue reading
 
This week, Jonathan is joined by John ‘Jack’ Cush, Director of Clinical Rheumatology at the Baylor Research Institute, Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine. Please use the following timestamps to navigate this episode: (00:00)-Introducti…
  continue reading
 
In this bonus episode, join EMJ host Dr Hannah Moir as she speaks with our two health and wellbeing experts, Dr Sula Windgassen and Kiera McGarrity, who provide their expertise and personal experiences of using intermittent catheters. The experts address the emotional impact of intermittent catheter use and provide solutions and practical tools to …
  continue reading
 
In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including: The diagnosis and typical presenting symptoms of GEP-NETs Findings from recent key phase III studies including NETTER-2 and CABINET Recommendations for treatment sequencing No…
  continue reading
 
In this second instalment Jonathan is joined by Sunil Gupta, Consultant Haematologist and haemato-oncologist based at Lewisham and Greenwich NHS Trust, UK, to delve further into prophylactic anticoagulation in APML patients with COVID-19 and, anthracycline toxicity, and new drug appraisals for NICE. Timestamps: (00:00)-Introduction (00:25)-Prophyla…
  continue reading
 
Moderated by Sue Saville. With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro. These podcasts were sponsored by Besins Healthcare.
  continue reading
 
Moderated by Sue Saville. With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro. These podcasts were sponsored by Besins Healthcare.
  continue reading
 
Moderated by Sue Saville. With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro. These podcasts were sponsored by Besins Healthcare.
  continue reading
 
Moderated by Sue Saville. With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro. These podcasts were sponsored by Besins Healthcare.
  continue reading
 
This week, Jonathan is joined by Mandeep Sagoo, Professor of Ophthalmology and Ocular Oncology, UCL Institute of Ophthalmology, London, UK. The pair explore ocular oncology and Mandeep’s groundbreaking work developing a digitally engineered 3D printed ocular prosthetic. Use the following timestamps to navigate this episode: (00:00)-Introduction (04…
  continue reading
 
This week, Jonathan is joined by Aniket Mohite, a distinguished member of the EMJ Oncology Editorial Board. Timestamps:     00:00 – Introduction 01:50 – Dr Aniket Mohite’s background and bio 02:35 – Dr Mohite’s journey into haematology-oncology: challenges and rewards 06:15 – How international experience shaped Dr Mohite’s practice 13:50 – Signific…
  continue reading
 
This week, Jonathan is joined by Kyle Richards, Associate Professor of Urology at the University of Wisconsin School of Medicine and Public Health, Madison, USA. The pair explore new treatment approaches for urologic cancers and the importance of patient education and comprehensive care. Use the following timestamps to navigate this episode: (00:00…
  continue reading
 
This week Jonathan is joined by Sunil Gupta, Consultant Haematologist and haemato-oncologist based at Lewisham and Greenwich NHS Trust, UK, to discuss the effects of COVID-19 on patients with haematological conditions, and medical education globally.   Timestamps:    (00:00)-Introduction (02:47)-Health benefits of yoga (06:25)-Yoga, mental health, …
  continue reading
 
In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented for ovarian, endometrial, and cervical cancer at the ESMO 2024 annual congress including: Phase III PRIMA/ENGOT-OV26/GOG-3012 Final OS Results: Niraparib as First-Line Maintenance in Advanced…
  continue reading
 
In this episode, listen to Matthew S. Davids, MD, MMSc​, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including: Contemporary treatment paradigms for patients with CLL Safety and efficacy of current regimens Molecular testing, including when and how to test for BTK inhibitor res…
  continue reading
 
Explore the importance of understanding and addressing vaccine hesitancy and consider the impact on uptake of vaccination strategies. Our discussion will consider the impact of the pandemic and the challenges and solutions associated with vaccine hesitancy in both HCPs and the public to build trust and vaccine uptake in the post-pandemic era. The p…
  continue reading
 
Explore the importance of the day-to-day practices, considering the importance of the environment and teamwork in the context of proactively preparing for vaccine distribution. Our discussion will consider implementation strategies, considering both pre and post-pandemic scenarios and the challenges and solutions associated with rapidly changing re…
  continue reading
 
Explore the significance of understanding vaccination technologies and platforms for COVID-19 in the post-pandemic era, focusing on safety and efficacy within the vaccination landscape, with regard to the technical aspects of vaccination types and vaccine response and durability. The publication of this podcast series was funded by Novavax.…
  continue reading
 
This week, Jonathan is joined by Cristian D’Alessandro, Chief Technology Officer at RespiQ, Leiden, the Netherlands. Together, they dive into the exciting world of medical technology, and discuss D’Alessandro’s revolutionary AI-enhanced breathalyser for detecting and monitoring COPD and other diseases. Timestamps:    (00:00)- Introduction   (02:43)…
  continue reading
 
This week, Divyanshu Dua joins Jonathan for the first episode of the Onc Now podcast series, highlighting innovation in oncology. The pair discuss the future of AI in the field, as well as the importance of treatment options for older patients. Timestamps:    (00:00)-Introduction   (02:13)-Dua’s journey into medicine (04:33)-Cancer care for older p…
  continue reading
 
George Cooper is joined by Perry Elliott, Professor of Cardiovascular Medicine at University College London, UK, and Anjali Owens, Associate Professor of Medicine in the Division of Cardiology at the Perelman School of Medicine of the University of Pennsylvania, USA. Following an incredible symposium session at the 2024 European Society of Cardiolo…
  continue reading
 
This week Jonathan is joined by Laren Tan, Associate Professor of Medicine, Loma Linda University Health in California, USA. Together, they address global healthcare needs, exploring innovative approaches to sustainability and equity. Please use the following timestamps to navigate this episode: (00:00)- Introduction  (03:36)- Laren’s unique hobby:…
  continue reading
 
This week Jonathan is joined by Ron Daniels, Founder and Executive Director of UK Sepsis Trust, and Vice President of the Global Sepsis Alliance. Together, they shatter myths and amplify awareness around sepsis, and discuss how to break barriers in diagnosis and treatment. Use the following timestamps to navigate this episode: (00:00)-Introduction …
  continue reading
 
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joshua E. Reuss, MD The phase 2 ICARUS-Lung01 study evaluated not only the efficacy and safety of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), but also potential biomarkers associated with response and/or resistance. Here to discuss…
  continue reading
 
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and beyond treatments in patients with recurrent ROS1-altered advanced NSCLC including: Assessing ROS1-TKI resistance mutations with tumor and liquid biopsies in patients with ROS1-altered advan…
  continue reading
 
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including: Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLC Long-term safety observations for cri…
  continue reading
 
This week, Jonathan is joined by Neal Shore, Medical Director at Carolina Urologic Research Center and Chief Medical Officer of Surgical Oncology and Urology at GenesisCare USA. In an enlightening conversation, they discuss the latest advancements in the field of urologic oncology and the wonderment of medicine. Timestamps:   (00:00)-Introduction  …
  continue reading
 
In this bonus episode of the EMJ podcast, co-hosts Eleonora De Martin, Consultant transplant hepatologist at the Centre Hépato-Biliaire, Paul Brousse Hospital in France, and patient advocate, Ingo van Thiel, from the German Liver Aid Association- Deut-sche Leber hilfe e.V., provide key insights from both the patient and clinician perspectives surro…
  continue reading
 
Valerie Gysberts, Functional and Nutritional Medicine Therapist, Beingwell Clinic, Melbourne, Australia and Jonathan Upfal, Integrated General Practitioner, National Institute of Integrative Medicine, Melbourne, Australia, discuss their medical practice with a diverse range of patients who have often been through the medical system but have seen no…
  continue reading
 
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …
  continue reading
 
Host: Jacob Sands, MD Guest: Aaron Lisberg, MD Brain metastases are a frequent complication of lung cancer, which is why the TROPION-Lung05 trial evaluated the intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced metastatic non-small cell lung cancer (NSCLC). According to the data, Dato-DXd demonst…
  continue reading
 
Dr. Wright shares insights into her transition to leading a major non-profit dedicated to improving the lives of those with COPD and other lung diseases. From predictive analytics to advocacy and awareness, discover how her visionary leadership is shaping the future of chronic disease management. Timestamps:  (00:00) -Introduction (03:16) -Jean’s j…
  continue reading
 
Shaping the field of cardiovascular medicine, emerging technologies have the potential to transform the treatment of vascular disease. Explore the latest advancements in cardiology with Jonathan and Nicholas Leeper, Professor of Surgery, Chief of Vascular Medicine, and Director of Vascular Research at Stanford University, California, USA. Timestamp…
  continue reading
 
Discover the remarkable progress made in heart failure therapies with Jonathan and Haider Warraich, Director of the Heart Failure Program at VA Boston Healthcare System, Massachusetts, USA. They also discuss the intricacies of heart transplantation and end-of-life care. Use the following timestamps to navigate the episode: (00:00)-Introduction (03:…
  continue reading
 
In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …
  continue reading
 
Azra Raza, Professor of Medicine and Director of the Myelodysplastic Syndrome (MDS) Center at Columbia University in New York, joins Jonathan Sackier to discuss her mission to shift the field of oncology, ensuring it focuses on eliminating the first cancer cell rather than chasing after the last. Timestamps:  (00:00)-Introduction (02:37)-Poetry (08…
  continue reading
 
Jonathan and Maria Eugenia Inda, Pew Postdoctoral Fellow at MIT Synthetic Biology Center in Cambridge, Massachusetts, discuss the latest developments in microbiome research and their potential applications in personalised health, as well as the fascinating world of agar art. Timestamps: (00:00)-Introduction (02:57)-Agar art (06:03)-Art influencing …
  continue reading
 
In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…
  continue reading
 
In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…
  continue reading
 
Jonathan Weitzman, professor of genetics at the Université Paris Cité in France, joins Jonathan Sackier to discuss the role of epigenetic events in cellular differentiation programmes, as well as his own podcast, ‘The Lonely Pipette’. Use the following timestamps to navigate this episode: (00:00)-Introduction (02:49)-Specialising in epigenetics (05…
  continue reading
 
In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…
  continue reading
 
In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…
  continue reading
 
Jonathan and Vindana Chibabhai, Associate Professor in the Department of Clinical Microbiology and Infectious Diseases at the University of the Witwatersrand, Johannesburg, South Africa, discuss novel tools for pathogen surveillance, and the future of microbiology. Timestamps: (00:00)-Introduction (03:20)-Podcast host to podcast host (04:50)-Vindan…
  continue reading
 
Loading …

Οδηγός γρήγορης αναφοράς